CD4-IgG (Genentech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCD4-IgG (Genentech)
Drug Alias NameAIDS passive immunizationCD4-Immunoadhesin Recombinant CD4-im munoglobulin G Re combinant soluble CD4- immunoglobulin G
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunoglobulin G agonists
TargetsImmunoglobulin G
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Genentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi ChemicalGenentech IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A